BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 26725323)

  • 1. KDM2B/FBXL10 targets c-Fos for ubiquitylation and degradation in response to mitogenic stimulation.
    Han XR; Zha Z; Yuan HX; Feng X; Xia YK; Lei QY; Guan KL; Xiong Y
    Oncogene; 2016 Aug; 35(32):4179-90. PubMed ID: 26725323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The FBXL10/KDM2B scaffolding protein associates with novel polycomb repressive complex-1 to regulate adipogenesis.
    Inagaki T; Iwasaki S; Matsumura Y; Kawamura T; Tanaka T; Abe Y; Yamasaki A; Tsurutani Y; Yoshida A; Chikaoka Y; Nakamura K; Magoori K; Nakaki R; Osborne TF; Fukami K; Aburatani H; Kodama T; Sakai J
    J Biol Chem; 2015 Feb; 290(7):4163-77. PubMed ID: 25533466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fbxl10/Kdm2b recruits polycomb repressive complex 1 to CpG islands and regulates H2A ubiquitylation.
    Wu X; Johansen JV; Helin K
    Mol Cell; 2013 Mar; 49(6):1134-46. PubMed ID: 23395003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kdm2b Regulates Somatic Reprogramming through Variant PRC1 Complex-Dependent Function.
    Zhou Z; Yang X; He J; Liu J; Wu F; Yu S; Liu Y; Lin R; Liu H; Cui Y; Zhou C; Wang X; Wu J; Cao S; Guo L; Lin L; Wang T; Peng X; Qiang B; Hutchins AP; Pei D; Chen J
    Cell Rep; 2017 Nov; 21(8):2160-2170. PubMed ID: 29166607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. KDM2B links the Polycomb Repressive Complex 1 (PRC1) to recognition of CpG islands.
    Farcas AM; Blackledge NP; Sudbery I; Long HK; McGouran JF; Rose NR; Lee S; Sims D; Cerase A; Sheahan TW; Koseki H; Brockdorff N; Ponting CP; Kessler BM; Klose RJ
    Elife; 2012 Dec; 1():e00205. PubMed ID: 23256043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KDM2B in polycomb repressive complex 1.1 functions as a tumor suppressor in the initiation of T-cell leukemogenesis.
    Isshiki Y; Nakajima-Takagi Y; Oshima M; Aoyama K; Rizk M; Kurosawa S; Saraya A; Kondo T; Sakaida E; Nakaseko C; Yokote K; Koseki H; Iwama A
    Blood Adv; 2019 Sep; 3(17):2537-2549. PubMed ID: 31471323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of Structural Elements of the Lysine Specific Demethylase 2B CxxC Domain Associated with Replicative Senescence Bypass in Primary Mouse Cells.
    Deiktakis EE; Abrams M; Tsapara A; Stournaras C; Tsatsanis C; Tsichlis PN; Kampranis SC
    Protein J; 2020 Jun; 39(3):232-239. PubMed ID: 32270414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kdm2b maintains murine embryonic stem cell status by recruiting PRC1 complex to CpG islands of developmental genes.
    He J; Shen L; Wan M; Taranova O; Wu H; Zhang Y
    Nat Cell Biol; 2013 Apr; 15(4):373-84. PubMed ID: 23502314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KDM2B promotes pancreatic cancer via Polycomb-dependent and -independent transcriptional programs.
    Tzatsos A; Paskaleva P; Ferrari F; Deshpande V; Stoykova S; Contino G; Wong KK; Lan F; Trojer P; Park PJ; Bardeesy N
    J Clin Invest; 2013 Feb; 123(2):727-39. PubMed ID: 23321669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Structure-Based Strategy for Engineering Selective Ubiquitin Variant Inhibitors of Skp1-Cul1-F-Box Ubiquitin Ligases.
    Gorelik M; Manczyk N; Pavlenco A; Kurinov I; Sidhu SS; Sicheri F
    Structure; 2018 Sep; 26(9):1226-1236.e3. PubMed ID: 30033217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of cell proliferation and induction of autophagy by KDM2B/FBXL10 knockdown in gastric cancer cells.
    Zhao E; Tang C; Jiang X; Weng X; Zhong X; Zhang D; Hou J; Wang F; Huang M; Cui H
    Cell Signal; 2017 Aug; 36():222-229. PubMed ID: 28506929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The H3K4me3 histone demethylase Fbxl10 is a regulator of chemokine expression, cellular morphology, and the metabolome of fibroblasts.
    Janzer A; Stamm K; Becker A; Zimmer A; Buettner R; Kirfel J
    J Biol Chem; 2012 Sep; 287(37):30984-92. PubMed ID: 22825849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KDM2B is a histone H3K79 demethylase and induces transcriptional repression via sirtuin-1-mediated chromatin silencing.
    Kang JY; Kim JY; Kim KB; Park JW; Cho H; Hahm JY; Chae YC; Kim D; Kook H; Rhee S; Ha NC; Seo SB
    FASEB J; 2018 Oct; 32(10):5737-5750. PubMed ID: 29763382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone demethylase KDM2B promotes triple negative breast cancer proliferation by suppressing p15INK4B, p16INK4A, and p57KIP2 transcription.
    Zheng Q; Fan H; Meng Z; Yuan L; Liu C; Peng Y; Zhao W; Wang L; Li J; Feng J
    Acta Biochim Biophys Sin (Shanghai); 2018 Sep; 50(9):897-904. PubMed ID: 30060056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysine-specific demethylase 2B (KDM2B)-let-7-enhancer of zester homolog 2 (EZH2) pathway regulates cell cycle progression and senescence in primary cells.
    Tzatsos A; Paskaleva P; Lymperi S; Contino G; Stoykova S; Chen Z; Wong KK; Bardeesy N
    J Biol Chem; 2011 Sep; 286(38):33061-9. PubMed ID: 21757686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NDY1/KDM2B functions as a master regulator of polycomb complexes and controls self-renewal of breast cancer stem cells.
    Kottakis F; Foltopoulou P; Sanidas I; Keller P; Wronski A; Dake BT; Ezell SA; Shen Z; Naber SP; Hinds PW; McNiel E; Kuperwasser C; Tsichlis PN
    Cancer Res; 2014 Jul; 74(14):3935-46. PubMed ID: 24853546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The epigenetic factor KDM2B regulates cell adhesion, small rho GTPases, actin cytoskeleton and migration in prostate cancer cells.
    Zacharopoulou N; Tsapara A; Kallergi G; Schmid E; Tsichlis PN; Kampranis SC; Stournaras C
    Biochim Biophys Acta Mol Cell Res; 2018 Apr; 1865(4):587-597. PubMed ID: 29408056
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of amino acid metabolism by KDM2B, in the context of ncPRC1.1 and in concert with MYC and ATF4.
    Chavdoula E; Anastas V; La Ferlita A; Aldana J; Carota G; Spampinato M; Soysal B; Cosentini I; Parashar S; Sircar A; Nigita G; Sehgal L; Freitas MA; Tsichlis PN
    Metabolism; 2024 Jan; 150():155719. PubMed ID: 37935302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence.
    Johmura Y; Sun J; Kitagawa K; Nakanishi K; Kuno T; Naiki-Ito A; Sawada Y; Miyamoto T; Okabe A; Aburatani H; Li S; Miyoshi I; Takahashi S; Kitagawa M; Nakanishi M
    Nat Commun; 2016 Feb; 7():10574. PubMed ID: 26868148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alternative isoforms of KDM2A and KDM2B lysine demethylases negatively regulate canonical Wnt signaling.
    Lađinović D; Pinkas D; Šopin T; Raška O; Liška F; Raška I; Vacík T
    PLoS One; 2020; 15(10):e0236612. PubMed ID: 33104714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.